Tectonic Therapeutic
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Tectonic Therapeutic generated cash of -$40,681,000, which is more than the previous year. Cash used in financing activities reached the amount of $33,747,000 last year. Net change in cash is therefore -$7,197,000.
Cash Flow
| 2017 | -16.38M | -383K | 17.37M |
|---|---|---|---|
| 2019 | -67.66M | -1.58M | 129.99M |
| 2022 | -97.20M | -267K | 262K |
| 2023 | -40.68M | -279K | 33.74M |
TECX Cash Flow Statement (2017 – 2023)
| 2023 | 2022 | 2019 | 2017 | |
|---|---|---|---|---|
Cash at beginning of period | 36.55M | 189.56M | 126.30M | 5.35M |
Operating activities | ||||
Net income | -42.82M | -105.89M | -72.96M | -18.64M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||
Depreciation and amortization | 617K | 4.16M | 850K | 45K |
Stock-based compensation expense | 1.12K | 1.11M | 0 | 0 |
| Deferred income tax benefit | 1.12K | 1.11M | 0 | 0 |
| Changes in operating assets and liabilities: | ||||
Accounts receivable, net | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 |
Accounts payable | -357K | -3.10M | 1.02M | 176K |
Cash generated by operating activities | -40.68M | -97.20M | -67.66M | -16.38M |
Investing activities | ||||
Purchases Of Investments | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -279K | -267K | -1.58M | -383K |
Acquisitions Net | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -279K | -267K | -1.58M | -383K |
Financing activities | ||||
Common Stock Issued | 321K | 0 | 129.99M | 17.41M |
Payments for dividends | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 |
Repayments of term debt | -499K | 0 | 0 | 0 |
Cash used in financing activities | 33.74M | 262K | 129.99M | 17.37M |
Net Change In Cash | -7.19M | -96.72M | 60.74M | 606K |
Cash at end of period | 29.35M | 92.84M | 187.04M | 5.96M |